Research News

Duloxetine reduces chemotherapy induced peripheral neuropathy

BMJ 2013; 346 doi: (Published 10 April 2013) Cite this as: BMJ 2013;346:f2199

OpenUrlCrossRefMedlineWeb of Science

The antidepressant duloxetine is the first drug shown to reduce pain in people with peripheral neuropathy after chemotherapy with taxanes or platinums. All participants in a placebo controlled crossover trial had moderate to severe pain for at least three months after chemotherapy, mostly paclitaxel …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial